Physician profile
Daniel A Rubin
NPI 1902862014
$8,249.31
in general payments reported to CMS, 2019-2025
36 companies · $1,790 in 2025
The $1,790 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,192 · 2020: $644 · 2021: $978 · 2022: $1,770 · 2023: $832 · 2024: $1,044 · 2025: $1,790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,625 · Education: $40.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,625.15 |
| Education | $40.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $706.89 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $696.04 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Amgen INC. | $633.82 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $620.60 | 2019-2025 | |
| Pfizer INC. | $555.58 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $552.85 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $436.33 | 2021-2025 | Verquvo |
| Novo Nordisk INC | $429.91 | 2021-2025 | Wegovy, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $381.79 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $318.36 | 2019-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $295.36 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $249.43 | 2019-2024 | |
| Amarin Pharma, INC. | $238.17 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $208.62 | 2022-2025 | Opsumit, Opsynvi, Uptravi |
| Cvrx, INC. | $182.62 | 2021-2023 | Barostim Neo System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $172.79 | 2020-2025 | Onpattro |
| Impulse Dynamics (USA) INC. | $156.86 | 2022 | |
| Daiichi Sankyo INC. | $155.61 | 2022-2025 | Injectafer |
| Heartflow, INC. | $151.84 | 2023-2025 | Ffrct |
| Esperion Therapeutics, INC. | $122.65 | 2021-2025 | Nexletol |
| Irhythm Technologies, INC. | $111.54 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Scpharmaceuticals INC. | $98.32 | 2024-2025 | |
| Abbott Laboratories | $96.63 | 2019-2023 | Jot Dx |
| Atricure, INC. | $93.39 | 2019-2022 | |
| Vifor Pharma, INC. | $89.52 | 2019-2022 | |
| Medtronic, INC. | $86.31 | 2021-2024 | Symplicity G3 |
| Boston Scientific Corporation | $81.13 | 2022-2025 | Cds - Mct/Cem Monitoring, Watchman |
| Kestra Medical Technology Services, INC. | $71.95 | 2022-2025 | Assure Wcd |
| Medtronic Vascular, INC. | $66.18 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $36.06 | 2021 | |
| Lundbeck LLC | $34.92 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $32.18 | 2022-2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $26.66 | 2019 | |
| Zoll Respicardia, INC. | $24.69 | 2023 | Remede System |
| Lantheus Medical Imaging, INC. | $19.86 | 2021 | |
| Inspire Medical Systems, INC. | $13.85 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.